ES2149952T3 - L-arginina y analogos como inhibidores de la agregacion de trombocitos. - Google Patents

L-arginina y analogos como inhibidores de la agregacion de trombocitos.

Info

Publication number
ES2149952T3
ES2149952T3 ES95900714T ES95900714T ES2149952T3 ES 2149952 T3 ES2149952 T3 ES 2149952T3 ES 95900714 T ES95900714 T ES 95900714T ES 95900714 T ES95900714 T ES 95900714T ES 2149952 T3 ES2149952 T3 ES 2149952T3
Authority
ES
Spain
Prior art keywords
arginine
inhibitors
analogs
thrombocyte aggregation
thrombocyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95900714T
Other languages
English (en)
Inventor
Jurgen C Prof Dr Med Frolich
Rainer H Boger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2149952T3 publication Critical patent/ES2149952T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA INVENCION SE REFIERE A LA UTILIZACION DE L-ARGININA Y SUS DERIVADOS COMO INHIBIDORES DE AGREGACION DE TROMBOCITOS PARA TRATAMIENTO DE PERTURBACIONES DE CIRCULACION CENTRAL Y PERIFERICAS, ASI COMO EL RECHAZO DE ORGANOS TRASPLANTADOS. ESTOS COMPUESTOS PUEDEN ALIVIAR LOS SINTOMAS PRODUCIDOS EN ESTAS CONDICIONES.
ES95900714T 1993-11-12 1994-11-11 L-arginina y analogos como inhibidores de la agregacion de trombocitos. Expired - Lifetime ES2149952T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4338793A DE4338793A1 (de) 1993-11-12 1993-11-12 L-Arginin und Analoge als Thrombozytenaggregationshemmer

Publications (1)

Publication Number Publication Date
ES2149952T3 true ES2149952T3 (es) 2000-11-16

Family

ID=6502515

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95900714T Expired - Lifetime ES2149952T3 (es) 1993-11-12 1994-11-11 L-arginina y analogos como inhibidores de la agregacion de trombocitos.

Country Status (5)

Country Link
EP (1) EP0679080B1 (es)
AT (1) ATE194282T1 (es)
DE (2) DE4338793A1 (es)
ES (1) ES2149952T3 (es)
WO (1) WO1995013060A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7629384B2 (en) 1997-09-17 2009-12-08 Strategic Science & Technologies, Llc Topical delivery of L-arginine to cause beneficial effects
ES2340450T3 (es) * 1997-09-17 2010-06-02 STRATEGIC SCIENCE & TECHNOLOGIES, LLC Un suministro de arginina para el calentamiento de tejidos frios/enfriados.
US7914814B2 (en) 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
WO2001057184A2 (en) * 2000-02-01 2001-08-09 Vanderbilt University Use of platelet activity modulators for inhibiting complement activation
DE10128934A1 (de) * 2001-06-18 2003-02-06 Bernhard Sibbe Wirkstoffzusammensetzung zur Vorbeugung gegen Angina-Pectoris-Beschwerden
US9050365B2 (en) 2004-04-19 2015-06-09 Strategic Science & Technologies, Llc Transdermal delivery of beneficial substances effected by a hostile biophysical environment
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
EP2445493A1 (en) 2009-06-24 2012-05-02 Strategic Science & Technologies, LLC Topical composition containing naproxen
AU2009348470B2 (en) 2009-06-24 2015-04-02 Strategic Science & Technologies, Llc Topical composition containing ibuprofen
US9463158B2 (en) 2009-06-24 2016-10-11 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
EP2658554A4 (en) 2010-12-29 2015-01-07 Strategic Science & Tech Llc SYSTEMS AND METHOD FOR THE TREATMENT OF ALLERGIES AND OTHER INDICATIONS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4308257A (en) * 1980-06-03 1981-12-29 Saul Caspe Accelerating cellular repair composition for the human body and method of administering same
US4732892A (en) * 1985-07-12 1988-03-22 American Home Products Corporation L-α-amino acids as transdermal penetration enhancers
US5053387A (en) * 1987-02-20 1991-10-01 Shriners Hospitals For Crippled Children Omega-3 fatty acids in traumatic injury treatment
EP0320976A1 (en) * 1987-12-18 1989-06-21 Ajinomoto Co., Inc. Arginine derivatives and cosmetic compositions comprising the same
EP0441119A3 (en) * 1990-01-09 1992-10-14 Richard D. Levere The use of l-arginine in the treatment of hypertension and other vascular disorders
JPH05163139A (ja) * 1991-12-12 1993-06-29 Ajinomoto Co Inc 抗動脈硬化剤
DE4305881C1 (de) * 1993-02-26 1994-03-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Wirkstoffen, welche Stichoxid-Quellen darstellen, Verfahren zu seiner Herstellung sowie seine Verwendung

Also Published As

Publication number Publication date
EP0679080B1 (de) 2000-07-05
ATE194282T1 (de) 2000-07-15
WO1995013060A1 (de) 1995-05-18
DE59409421D1 (en) 2000-08-10
EP0679080A1 (de) 1995-11-02
DE4338793A1 (de) 1995-05-18

Similar Documents

Publication Publication Date Title
ES2149952T3 (es) L-arginina y analogos como inhibidores de la agregacion de trombocitos.
FI931370A (fi) Kvaeve innehaollande analoger av icke-aromatiska heterocykliska foereningar med en fusionerad ring
DE69200685T2 (de) Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3-Benzazepin-2-ones, verwendbar in der Behandlung von kardiovaskularen Krankheiten.
DE3674941D1 (de) Ozonentkeimung von blut und blutprodukten.
HN1998000143A (es) Tetrahidronaftalenos substituidos y compuestos analogos.
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE3752112D1 (de) Verwendung von Inositoltriphosphat zur Behandlung von Entzündungen
ATE225176T1 (de) Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie
FR2365553A1 (fr) Derives amides de pentapeptides et tetrapeptides et leur utilisation comme medicaments
ES2135769T3 (es) Derivados de isotiourea como inhibidores de no-sintasa.
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
ATE59781T1 (de) Potenzierung von prazosin.
ATE167804T1 (de) Verwendung von nickel und bromide ionen für die behandlung von psoriasis
MX9300205A (es) Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene.
ATE112168T1 (de) Menschlicher hitzeschock-faktor.
DE69021128D1 (de) Interleukin-1-Inhibitor.
FR2362852A1 (fr) Derives de la phenothiazine, leur preparation et leurs utilisations therapeutiques
BE860162A (fr) Derives actifs de l'uree leur procede de preparation ainsi que les compositions therapeutiques les contenant
FR2355846A1 (fr) Esters de penicillines utilisables comme medicaments
TR200103398T2 (tr) íkameli fenilsikloheksankarboksamitler ve bunlarìn adenozin alìnìmìnìn inhibit”rleri olarak kullanìmì
FR2446833A1 (fr) Octahydro-2h-pyrrolo(3,4-g)quinoleines et leur utilisation therapeutiques
ATE62789T1 (de) Mittel zur bekaempfung von phytopathogenen mikroben.
DE69209291D1 (de) Führung für den rand des wulstes bei wulstbeschichtung
DE60119336D1 (de) Verwendungen von thaliporphin oder seinen derivaten in der behandlung von herzkrankheiten und seine herstellung
DE68912472T2 (de) Verwendung von Retinoiden.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 679080

Country of ref document: ES